Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Sarabi

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Gastroenterology|October 15, 2013
Obscure bleeding colonic duplication responds to proton pump inhibitor therapyJérémie Jacques, Fabrice Projetti, Romain Legros, et al.
Immunotherapy|August 4, 2018
Primary malignant melanoma of the esophagus, treated with immunotherapy: a case reportPauline Rochefort, Juliette Roussel, Arnaud de la Fouchardière, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancerRomain Cohen, Vincent Jonchère, Christelle De La Fouchardière, et al.
Journal of Personalized Medicine|April 23, 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Frontiers in Oncology|October 11, 2021
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case ReportRomain Varnier, Thibaut Garrivier, Emilie Hafliger, et al.
British Journal of Cancer|March 27, 2021
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohortEdouard Auclin, Lysiane Marthey, Raef Abdallah, et al.
Oncotarget|December 20, 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO studyJuliette Palle, David Tougeron, Astrid Pozet, et al.
Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
Nature Medicine|May 10, 2011
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Gastroenterology|October 15, 2013
Obscure bleeding colonic duplication responds to proton pump inhibitor therapyJérémie Jacques, Fabrice Projetti, Romain Legros, et al.
Immunotherapy|August 4, 2018
Primary malignant melanoma of the esophagus, treated with immunotherapy: a case reportPauline Rochefort, Juliette Roussel, Arnaud de la Fouchardière, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancerRomain Cohen, Vincent Jonchère, Christelle De La Fouchardière, et al.
Journal of Personalized Medicine|April 23, 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Frontiers in Oncology|October 11, 2021
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case ReportRomain Varnier, Thibaut Garrivier, Emilie Hafliger, et al.
British Journal of Cancer|March 27, 2021
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohortEdouard Auclin, Lysiane Marthey, Raef Abdallah, et al.
Oncotarget|December 20, 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO studyJuliette Palle, David Tougeron, Astrid Pozet, et al.
Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
Nature Medicine|May 10, 2011
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, et al.
Pageof 3